Patents by Inventor Hsiang-Fu Kung

Hsiang-Fu Kung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Plant protein useful for treating tumors and HIV infection
    Patent number: 5484889
    Abstract: A protein, in particular MAP 30, obtainable from both the fruit and seeds of Momordica charantia or produced by recombinant means useful for treating tumors and HIV infections is disclosed. In treating HIV infections, the protein is administered alone or in conjunction with conventional AIDS therapies. Also provided are processes for purifying the protein, DNA sequences encoding the protein, and recombinant DNA methods for expressing the protein.
    Type: Grant
    Filed: July 21, 1994
    Date of Patent: January 16, 1996
    Assignees: New York University, American Biosciences, Inc., The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Sylvia Lee-Huang, Philip L. Huang, Peter L. Nara, Hao-Chia Chen, Hsiang-fu Kung, Peter Huang, Henry I. Huang, Paul L. Huang
  • Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof
    Patent number: 5317009
    Abstract: New proteins, termed GAP 31, obtainable from the seeds of Gelonium multiflorum, and DAP 30 and DAP 32, obtainable from the leaves or seeds of Dianthus caryophyllus, or the above proteins produced by recombinant means, are useful for treating HIV infections. In treating HIV infections, the protein is administered alone or in conjunction with other anti-HIV therapeutics. Also provided are processes for purifying the proteins, DNA sequences encoding the proteins, hosts expressing the proteins, recombinant DNA methods for expressing the proteins, and antibodies specific for the proteins.
    Type: Grant
    Filed: August 26, 1991
    Date of Patent: May 31, 1994
    Assignees: New York University, American Biosciences, Inc., National Institutes of Health
    Inventors: Sylvia Lee-Huang, Hsiang-fu Kung, Paul L. Huang, Philip L. Huang, Peter Huang, Henry I. Huang, Hao-chia Chen
  • Immune interferon
    Patent number: 5278286
    Abstract: An intact human immune interferon protein and a method for the extraction and purification of intact recombinant human immune interferon is disclosed. This method permits the purification to homogenity of intact recombinant human immune interferon.
    Type: Grant
    Filed: February 19, 1987
    Date of Patent: January 11, 1994
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Hsiang-Fu Kung, Hiromu Sugino, Susumu Honda
  • Immune interferon and a method for its extraction and purification
    Patent number: 4681930
    Abstract: An intact human immune interferon protein and a method for the extraction and purification of intact recombinant human immune interferon is disclosed. This method permits the purification to homogenity of intact recombinant human immune interferon.
    Type: Grant
    Filed: August 10, 1984
    Date of Patent: July 21, 1987
    Assignees: Hoffmann-La Roche Inc., Takeda Chemical Industries Ltd.
    Inventors: Hsiang-Fu Kung, Hiromu Sugino, Susumu Honda
  • Crystalline human leukocyte interferon
    Patent number: 4672108
    Abstract: The crystallization of human leukocyte interferon is described. In a preferred embodiment crystalline recombinant human leukocyte interferon A (IFL-rA) is prepared.
    Type: Grant
    Filed: July 3, 1985
    Date of Patent: June 9, 1987
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Hsiang-Fu Kung, David L. Miller, Sidney Pestka
  • Homogeneous immune interferon fragment
    Patent number: 4604284
    Abstract: An active fragment of human immune interferon and a method for the extraction and purification of this protein fragment is disclosed. This method permits the purification to homogenity of the active fragment of recombinant human immune interferon.
    Type: Grant
    Filed: September 20, 1983
    Date of Patent: August 5, 1986
    Assignees: Hoffmann-La Roche Inc., Takeda Chemical Industries Ltd.
    Inventors: Hsiang-Fu Kung, Hiromu Sugino, Susumu Honda
  • Method for the extraction of immune interferon
    Patent number: 4476049
    Abstract: A method for the extraction of intact recombinant human immune interferon with guanidine-HCl is disclosed. This method permits the purification to homogenity of intact recombinant human immune interferon.
    Type: Grant
    Filed: September 20, 1983
    Date of Patent: October 9, 1984
    Assignee: Hoffmann-La Roche Inc.
    Inventor: Hsiang-Fu Kung